stock listing Protein Sequencing Firm Quantum-Si to Go Public Through Special Purpose Acquisition Company Merger The proteomics firm is expected to receive $514 million in proceeds through the deal, including a $425 million private investment in public equity (PIPE) transaction. Nautilus Biotechnology to Go Public on Nasdaq Through Merger With Special Purpose Acquisition Firm The proteomics firm is expected to receive $350 million in proceeds through the deal, including a $200 million private investment in public equity (PIPE) transaction. Bionano Genomics Stock Soars on User Presentations, Public Stock Offering, Renewed Nasdaq Compliance Buoyed by a string of positive news, the San Diego firm's stock was up 22 percent in Friday afternoon trading and 80 percent from last week. T2 Biosystems Regains Compliance With Nasdaq Listing Requirements In April the firm received notice that it wasn't in compliance because its common stock didn't maintain a minimum bid price of $1.00 for 30 consecutive business days. Biocept Files $100M Shelf Registration The company plans to use the proceeds to support a variety of general expenses, including research and development, administration, sales, marketing, and capital expenditures. May 3, 2019 Genetic Technologies Out of Compliance With Nasdaq Listing Rules Mar 22, 2018 Bio-Rad Receives Notice From NYSE for Late Filing of Annual Report Jan 9, 2018 Genetic Technologies Regains Compliance With Nasdaq Listing Rules Oct 18, 2017 Novacyt Raises €9.7M Aug 31, 2017 Interpace Regains Compliance With Nasdaq Listing Rule Jul 14, 2017 BGI Genomics Raises RMB 547M in IPO Jun 22, 2017 OpGen Warned by Nasdaq of Non-Compliance Apr 13, 2017 Interpace Diagnostics Regains Nasdaq Compliance Feb 21, 2017 Transgenomic Delisted from Nasdaq Jan 25, 2017 Biocept Regains Nasdaq Compliance Jan 17, 2017 Interpace Dx Regains Compliance With Nasdaq Listing Requirement Dec 15, 2016 WaferGen Regains Compliance With Nasdaq Listing Requirements Nov 28, 2016 Signal Genetics Regains Compliance With Nasdaq Listing Requirement Jul 11, 2016 Interpace Dx Gets Additional Time to Comply With Nasdaq Listing Requirements Jan 19, 2016 Toronto Stock Exchange Reviewing GeneNews' Eligibility for Continued Listing Feb 6, 2015 VolitionRx Begins Trading on NYSE MKT, Prices Public Offering at $3.75 per Share Feb 4, 2015 Genetic Technologies Regains Compliance with Nasdaq Listing Requirement, Works to Meet Another Requirement Dec 6, 2012 NeoGenomics Moves to Nasdaq Capital Market May 30, 2012 Trovagene Prices Public Offering as it Effects Reverse Stock Split and Moves to Nasdaq Apr 23, 2012 Rosetta Genomics Warned by Nasdaq on Second Listing Compliance Issue Load More Breaking News Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates Veracyte Q2 Revenues More Than Double on Test Volume Spike Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent Qiagen Q2 Revenues Grow 28 Percent CareDx Q2 Revenues Up 77 Percent Secondary Genetic Findings Often Requested if Given Second Chance, Study Finds The Scan Booster Push New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high. With Help from Mr. Fluffington, PurrhD Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic. Man Charged With Threatening to Harm Fauci, Collins The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials. Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.